CHLOROTHIAZIDE Drug Patent Profile
✉ Email this page to a colleague
When do Chlorothiazide patents expire, and what generic alternatives are available?
Chlorothiazide is a drug marketed by Abc Holding, Hikma Intl Pharms, Lederle, Mylan, Sandoz, Watson Labs, Hikma, Am Regent, Fresenius Kabi Usa, Rk Pharma, Sagent Pharms Inc, and Sun Pharm. and is included in twenty-three NDAs.
The generic ingredient in CHLOROTHIAZIDE is chlorothiazide sodium. There are forty-two drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the chlorothiazide sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Chlorothiazide
A generic version of CHLOROTHIAZIDE was approved as chlorothiazide sodium by FRESENIUS KABI USA on October 16th, 2009.
Summary for CHLOROTHIAZIDE
| US Patents: | 0 |
| Applicants: | 12 |
| NDAs: | 23 |
| Raw Ingredient (Bulk) Api Vendors: | 98 |
| Clinical Trials: | 8 |
| Patent Applications: | 5,184 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for CHLOROTHIAZIDE |
| DailyMed Link: | CHLOROTHIAZIDE at DailyMed |
Recent Clinical Trials for CHLOROTHIAZIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Virginia | Phase 4 |
| Vanderbilt University | Phase 4 |
| National Heart, Lung, and Blood Institute (NHLBI) | Phase 1 |
Medical Subject Heading (MeSH) Categories for CHLOROTHIAZIDE
Anatomical Therapeutic Chemical (ATC) Classes for CHLOROTHIAZIDE
US Patents and Regulatory Information for CHLOROTHIAZIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abc Holding | CHLOROTHIAZIDE | chlorothiazide | TABLET;ORAL | 085569-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Rk Pharma | CHLOROTHIAZIDE SODIUM | chlorothiazide sodium | INJECTABLE;INJECTION | 202493-001 | Jun 18, 2014 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Mylan | CHLOROTHIAZIDE-RESERPINE | chlorothiazide; reserpine | TABLET;ORAL | 087745-001 | May 6, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Mylan | CHLOROTHIAZIDE | chlorothiazide | TABLET;ORAL | 084217-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
